CA2180624A1 - Diphenyl-1,2,3-thiadiazoles, agents anti-inflammatoires - Google Patents

Diphenyl-1,2,3-thiadiazoles, agents anti-inflammatoires

Info

Publication number
CA2180624A1
CA2180624A1 CA 2180624 CA2180624A CA2180624A1 CA 2180624 A1 CA2180624 A1 CA 2180624A1 CA 2180624 CA2180624 CA 2180624 CA 2180624 A CA2180624 A CA 2180624A CA 2180624 A1 CA2180624 A1 CA 2180624A1
Authority
CA
Canada
Prior art keywords
formula
thiadiazoles
diphenyl
inflammatory agents
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2180624
Other languages
English (en)
Other versions
CA2180624C (fr
Inventor
Cheuk Kun Lau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Canada Inc
Original Assignee
Merck Frosst Canada and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603425.1A external-priority patent/GB9603425D0/en
Application filed by Merck Frosst Canada and Co filed Critical Merck Frosst Canada and Co
Publication of CA2180624A1 publication Critical patent/CA2180624A1/fr
Application granted granted Critical
Publication of CA2180624C publication Critical patent/CA2180624C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA 2180624 1995-07-12 1996-07-05 Diphenyl-1,2,3-thiadiazoles, agents anti-inflammatoires Expired - Fee Related CA2180624C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US107195P 1995-07-12 1995-07-12
US60/001,071 1995-07-12
GBGB9603425.1A GB9603425D0 (en) 1996-02-19 1996-02-19 Diphenyl-1 2 3-thiadiazoles as anti-inflammatory agents
GB9603425.1 1996-02-19

Publications (2)

Publication Number Publication Date
CA2180624A1 true CA2180624A1 (fr) 1997-01-13
CA2180624C CA2180624C (fr) 2006-12-12

Family

ID=26308753

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2180624 Expired - Fee Related CA2180624C (fr) 1995-07-12 1996-07-05 Diphenyl-1,2,3-thiadiazoles, agents anti-inflammatoires

Country Status (1)

Country Link
CA (1) CA2180624C (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6887893B1 (en) 1997-12-24 2005-05-03 Sankyo Company, Limited Methods and compositions for treatment and prevention of tumors, tumor-related disorders and cachexia
US7320996B2 (en) 2001-08-15 2008-01-22 Sugen, Inc Indolinone protein kinase inhibitors and cyclooxygenase inhibitors for use in combination therapy for the treatment of cancer
WO2022195579A1 (fr) 2021-03-15 2022-09-22 Saul Yedgar Dipalmitoyl-phosphatidyl-éthanol-amine conjuguée à l'acide hyaluronique en combinaison avec des médicaments anti-inflammatoires non stéroïdiens (ains) pour traiter ou soulager des maladies inflammatoires

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010000465A (es) 2007-07-12 2010-08-30 Tragara Pharmaceuticals Inc Metodos y composiciones para el tratamiento de cancer, tumores y alteraciones relacionadas con tumores.

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6887893B1 (en) 1997-12-24 2005-05-03 Sankyo Company, Limited Methods and compositions for treatment and prevention of tumors, tumor-related disorders and cachexia
US7745481B2 (en) 1997-12-24 2010-06-29 Daiichi Sankyo Company, Limited Methods and compositions for the treatment and prevention of tumors, tumor-related disorders and cachexia
US7320996B2 (en) 2001-08-15 2008-01-22 Sugen, Inc Indolinone protein kinase inhibitors and cyclooxygenase inhibitors for use in combination therapy for the treatment of cancer
WO2022195579A1 (fr) 2021-03-15 2022-09-22 Saul Yedgar Dipalmitoyl-phosphatidyl-éthanol-amine conjuguée à l'acide hyaluronique en combinaison avec des médicaments anti-inflammatoires non stéroïdiens (ains) pour traiter ou soulager des maladies inflammatoires

Also Published As

Publication number Publication date
CA2180624C (fr) 2006-12-12

Similar Documents

Publication Publication Date Title
CA2219115A1 (fr) Acides n-benzyl-3-indolacetiques en tant qu'inhibiteurs de la cycloozygenase-2 et medicaments anti-inflammatoires
CA2260016A1 (fr) Pyridines substituees en tant qu'inhibiteurs selectifs de la cyclo-oxygenase-2
DE69514813D1 (en) Bicyclische diarylheterocyclen als cyclooxygenase-2-inhibitoren
ES2165969T3 (es) Compuestos nitrogenados aromaticos condensados 5,5 aril-sustituidos como agentes antiinflamatorios.
PT828724E (pt) Diaril-5-oxigenadas-2-(5h)-furanonas comoinibidoras de cox-2
CA2301742A1 (fr) Pyridines 2,3,5-trisubstituees utilisees comme inhibiteurs de la cyclo-oxygenase 2
CA2283399A1 (fr) Pyridazinones utilises comme inhibiteurs de cyclo-oxygenase-2
ATE232856T1 (de) Diaryl-2(5h)-fuaranone als cox-2-inhibitoren
LU91145I9 (fr)
NZ516347A (en) Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them
CA2293823A1 (fr) Derives de homo-erythromycine a -9-deoxo-9a-aza-9aa substitution en position 4
EE200100558A (et) Triarüülhappe derivaat, seda sisaldav farmatseutiline kompositsioon ja ühendi raviotstarbeline kasutamine
CA2258548A1 (fr) Derives tricycliques substitues par phenylamino, destines au traitement des maladies hyperproliferatives
EP0908182A4 (fr) Preparations servant a la prevention et au traitement de maladies provoquees par une hypofonction de l'oxyde nitrique synthase
CA2234642A1 (fr) 3,4-diaryle-2-hydroxy-2,5-dihydrofurans utilises comme promedicaments pour inhibiteurs de cox-2
CA2211320A1 (fr) 5-methanesulfonamido-3h-isobenzofuran-1-ones utilises comme inhibiteurs de cyclooxygenase-2
CA2314154A1 (fr) Derives d'azepine et leur utilisation comme produits pharmaceutiques
WO1999033450A3 (fr) Agents therapeutiques
BR9503572A (pt) Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença
CA2301590A1 (fr) 2-aminopyridines utilisees comme inhibiteurs de la cyclo-oxygenase 2
CA2279184A1 (fr) Compositions pharmaceutiques contenant de l'ibuprofene et de la domperidone pour le traitement de la migraine
PL328225A1 (en) Diphenylstilbenes as pro-medications used to produce cox-2-inhibitors
CA2180624A1 (fr) Diphenyl-1,2,3-thiadiazoles, agents anti-inflammatoires
DE69600272D1 (de) Chinolin-4-carbonylguanidin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
CA2252401A1 (fr) Pyridinyl-2-cyclopenten-1-ones utilisees comme inhibiteurs de cyclooxygenase selectifs

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed